Delivery Order SPE2DB20D2014-SPE2DB25FC73P
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $41,658.25 to supply Tresiba FlexTouch 100 Unit/mL in 3mL quantities. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, with a ceiling value of $3,467.02 and a completion date of November 19, 2025. This is a firm fixed price delivery order issued without set-aside designation, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,340.08 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/mL in 3mL quantities. This is a firm fixed price delivery order under a non-set-aside competitive procurement, with an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $11,486.60 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The contract is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order valued at $4,019.90 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This non-competitive, firm fixed price delivery order was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,093.27 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL insulin pens. This competitively awarded, firm fixed-price contract was issued on January 8, 2026, with an ultimate completion date of January 9, 2026. The pharmaceutical products will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $2,667 to Amerisourcebergen Drug Corporation for Tresiba FlexTouch insulin. As the prime contractor, Amerisourcebergen will supply 200 units per milliliter of the drug in 3 milliliter packages to the DLA under a July 7-10, 2023 period of performance. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will fulfill the contract from its Conshohocken, Pennsylvania location utilizing its own...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,781.10. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,152.30 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC73PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,152.60 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/ML in 3ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Tresiba, an insulin product commonly used in diabetes management, represents one of many specialty and brand-name medications the contractor furnishes through this vehicle to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/13/25 |